MYLAN 2250 MYLAN 2250 Pill: tan purple, capsule/oblong, 19mm
The pill with imprint MYLAN 2250 MYLAN 2250 (Tan / Purple, Capsule/Oblong, 19mm) has been identified as Mycophenolate Mofetil 250 mg and is used for Organ Transplant, Rejection Prophylaxis. It belongs to the drug class selective immunosuppressants and is not a controlled substance.
Images for MYLAN 2250 MYLAN 2250
Mycophenolate Mofetil
- Imprint
- MYLAN 2250 MYLAN 2250
- Strength
- 250 mg
- Color
- Tan / Purple
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
corn starch,
sodium lauryl sulfate,
ferrosoferric oxide,
FD&C Blue No. 2,
gelatin,
ferric oxide red,
titanium dioxide,
ferric oxide yellow,
ammonia,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-2250 | Mylan Pharmaceuticals Inc. |
| 51079-0721 | UDL Laboratories Inc. |
See also:
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (60)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
Other brands
Professional resources
- Mycophenolate monograph
- Mycophenolate (FDA)
- Mycophenolate Mofetil (FDA)
- Mycophenolate Mofetil Injection (FDA)
- Mycophenolate Suspension (FDA)
- Mycophenolate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.